Dad Builds Two Biotech Firms to Save His Kids' Lives

John Crowley's world changed forever when his babies, Megan and Patrick, were diagnosed with Pompe disease, a rare and fatal form of muscular dystrophy. Most parents would have felt helpless, but Crowley rewrote the rules entirely.

Instead of accepting the diagnosis, he reinvented his entire career in a desperate race against time. With no background in biotech, Crowley dove into the industry and founded not one but two biotechnology companies focused on rare diseases.

The stakes couldn't have been higher. Pompe disease destroys muscles throughout the body, and without treatment, children rarely live past their first birthday. Every day mattered in the search for a therapy that could save his children's lives.

Crowley's determination paid off in ways that extend far beyond his own family. Both companies he built were eventually acquired by larger pharmaceutical corporations, bringing their research and treatments to a much wider patient population. His work helped create pathways for treatments that might never have existed otherwise.

Today, Megan and Patrick are alive, defying the odds they faced as infants. Their father now serves as CEO of BIO, the biotechnology industry's leading lobbying organization, where he continues advocating for rare disease research and treatment access.

The Ripple Effect

Crowley's journey transformed more than just his family's fate. His story inspired the 2010 film "Extraordinary Measures" and demonstrated that one person's determination can reshape an entire industry.

The companies he founded pioneered approaches to rare disease treatment that other biotech firms now follow. His work helped prove that even the smallest patient populations deserve investment and innovation.

Beyond the science, Crowley showed other families facing devastating diagnoses that hope isn't passive. Sometimes hope means rolling up your sleeves, learning an entirely new field, and building the solution yourself when it doesn't exist.

His path from desperate parent to industry leader created a roadmap for others. Families affected by rare diseases now have more resources, more advocacy, and more reasons to believe that cures are possible.

The race that began with two sick babies has touched countless lives, proving that love combined with action can move mountains.